Fava Health builds design‑led digital solutions that embed genomic data into existing electronic health records and clinical workflows, providing real‑time decision support and population health analytics for health systems. It also offers strategic consultancy and API tools for life‑science companies to integrate genomic insights into their products, plus at‑home pharmacogenomic testing kits that feed actionable results back to providers.
Funding
Funding not disclosed
Founders
Product
Problem
Health systems struggle to incorporate rapidly advancing genomic data into routine clinical workflows, leading to missed opportunities for personalized care and cost savings. The complexity of integrating new genomic insights with existing IT infrastructure and decision processes creates barriers to widespread implementation.
Solution
Fava Health addresses this gap by designing and delivering digital solutions that embed genomic information directly into the electronic health record and clinical pathways of health systems. Their platform provides real-time decision support, population-level analytics, and seamless interoperability with existing IT systems, enabling clinicians to act on genetic insights at the point of care. For life‑science companies, Fava Health offers strategic consultancy to accelerate the translation of genomic and digital technologies into marketable products, helping prioritize projects and maximize return on investment. Additionally, they partner with healthcare providers to offer at‑home genetic testing kits that inform patients about medication response, supporting safer and more effective prescribing.
Target Audience
Primary customers are health system administrators and clinicians seeking to integrate genomics into routine care, pharmaceutical and biotech firms developing genomic‑driven products, and individual patients interested in pharmacogenomic testing through their providers.
Features
- Integration layer that connects genomic data sources to EHRs and clinical workflow engines without requiring major system overhauls
- Real-time, evidence‑based decision support alerts that guide medication selection and dosing based on a patient’s genetic profile
- Population health dashboards that aggregate genomic insights to identify at‑risk groups and track outcomes across the health system
- Customizable API suite for life‑science partners to embed genomic analytics into their product pipelines
- End‑to‑end consultancy services covering project scoping, regulatory strategy, and implementation planning for genomic initiatives
- At‑home genetic testing kit program with secure data transfer to providers, delivering actionable pharmacogenomic reports to patients